Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECASS III
NCT00153036Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2003
- Primary completion
- Feb 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 19
01
Overview
A Phase 3 trial of alteplase in ischemic stroke, sponsored by Boehringer Ingelheim. Started Apr 2003; status: completed.
02
Drugs
alteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00153036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153036.